| 2-aMino-6-fluoro-N-phenylbenzaMide hydrochloride |
1417456-04-2 |
C13H11N2OF.HCl |
| 2-AMino-6-flouro-N-phenylbenzaMide |
60041-89-6 |
C13H11N2OF |
| 2-Fluoro-6-nitro-N-phenylbenzamide |
870281-83-7 |
C13H9N2O3F |
| Idelalisib |
1146702-54-6 |
|
| 1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- |
881677-11-8 |
C16H11N2O3FS |
| PYRIDINE-3-SULFONYL CHLORIDE |
42899-76-3 |
C5H4NO2Scl.HCl |
| 1H-Pyrrole-3-carboxaldehyde, 5-(2-fluorophenyl)- |
881674-56-2 |
C11H8NOF |
| Vonoprazan |
881681-00-1 |
C17H16N3O2FS |
| BENZYL [1-[4-[[(4-FLUOROBENZYL)AMINO]CARBONYL]-5-HYDROXY-1-METHYL-6-OXO-1,6-DIHYDROPYRIMIDIN-2-YL]-1-METHYLETHYL]CARBAMATE |
518048-02-7 |
C24H25N4O5F |
| 4-PYRIMIDINECARBOXYLIC ACID, 1,6-DIHYDRO-5-HYDROXY-2-[1-METHYL-1-[[(PHENYLMETHOXY)CARBONYL]AMINO]ETHYL]-6-OXO-, METHYL ESTER |
519032-08-7 |
C17H19N3O6 |
| 5-Methyl-1,3,4-oxadiazole-2-carboxylic acid potassium salt |
888504-28-7 |
C4H3N2O3-.K+ |
| 2-(1-AMINO-1-METHYLETHYL)-N-(4-FLUOROBENZYL)-5-HYDROXY-1-METHYL-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE |
518048-03-8 |
C16H19N4O3F |
| Raltegravir |
518048-05-0 |
C26H29N6O11F |
| Raltegravir potassium |
871038-72-1 |
C20H20N6O5F-.K+ |
| Treprostinil intermediate |
101692-01-7 |
|
| (1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol |
101692-02-8 |
C21H32O3 |
| (S)-dec-1-yn-5-ol; 1-Decyn-5-ol,(5S) |
848609-05-2 |
C10H18O |
| 2-ALLYL-3-HYDROXYBENZALDEHYDE |
79950-42-8 |
C10H10O2 |
| Treprostinil |
81846-19-7 |
C23H30DO5 |
| Treprostinil Sodium |
289480-64-4 |
C23H33O5-.Na+ |
